ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Condromed 200 mg / 250 mg, Hartkapseln - 90
68626002 IBSA Institut Biochimique SA
Condromed 200 mg / 250 mg, Hartkapseln11.01.2023
  11.01.2023
Other Specific Antirheumatic Agents (M01CX) 
WHO-DDD10.01.2028
90
07.10.60. 
B  
No 
  
PR  
k.A.PR
  
7680686260023Biotechnologika
  
Composition
glucosamini hydrochloridum 250 mg, chondroitini sulfas natricus 200 mg corresp. natrium 18 mg, magnesii stearas, materiale di capsula: gelatina, E 132, E 171, pro capsula.
Packungsbestandteile
Capsules
 
Active AgentDose
Chondroitine Sodium Sulfate200 mg correspond Sodium 18 mg
Glucosamini Hydrochloridum250 mg
 
Inactive agents additional_information
E 132 color.
E 171 color.
Gelatina materiale di capsula
Magnesii Stearas  
Pro Capsula  
Source
Data was imported : 07.02.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home